Stephanie Schonewald will speak and Anita Spieth will moderate on the panel, “Public Disclosures and Patent Risks: US vs EP Perspectives” at the BIO IP Counsels Committee (BIO IPCC) Conference on Tuesday, November 18, 2025, from 9:00 to 10:15 a.m. The panel will discuss how mandatory disclosures, such as clinical trial postings, can complicate obtaining patent rights, and examine how public disclosures impact patentability, comparing US and Europe’s provisions requiring disclosure and implications on prosecution. Please visit the BIO IPCC website for more information about the conference and registration.